This photo shows panax notoginseng fruits at a panax notoginseng cultivation base in Lianhuatang Town of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, Nov. 5, 2022.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Photo by Chen Mingkai/Xinhua)
Farmers fertilize a panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
This aerial photo shows a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Zhou Dixiao)
A woman works at a packing workshop of a pharmaceutical company in Wenshan City, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Zhou Dixiao)
A farmer fertilizes the panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
A farmer fertilizes a panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Jiang Wenyao)
A farmer is pictured at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
Staff members work at a pharmaceutical company in Wenshan City, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Zhang Haobo)
Farmers work at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
Staff members work at a packing workshop of a pharmaceutical company in Wenshan City, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Zhang Haobo)
Farmers are pictured at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
Famers pose for a group photo at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
Famers pose for a group photo at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
This photo shows wild panax notoginseng in Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
A farmer checks the growth of panax notoginseng in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
A farmer fertilizes a panax notoginseng field in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Jiang Wenyao)
Famers pose for a group photo at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
This aerial photo shows a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Jiang Wenyao)
A farmer is pictured at a panax notoginseng cultivation base in Lianhuatang Township of Xichou County, Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, May 31, 2023.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Xinhua/Lan Hongguang)
People sort panax notoginseng products at a market in Wenshan Zhuang and Miao Autonomous Prefecture, southwest China's Yunnan Province, Nov. 27, 2022.
The cultivation of panax notoginseng in Wenshan has a rich historical legacy. In recent years, Wenshan has made great efforts to promote its biopharmaceutical industry centered around panax notoginseng, encouraging farmers to engage in standardized and large-scale cultivation. Collaboration with local pharmaceutical companies has played a pivotal role in enhancing the value-added aspects of Panax notoginseng, leading to increased income for farmers and effectively contributing to rural revitalization. In 2022, the cultivation area of panax notoginseng in Wenshan exceeded 2.3 million mu (about 153,333 hectares), and the comprehensive output value of the biopharmaceutical industry based on panax notoginseng surpassed 31 billion yuan (about 4.36 billion U.S. dollars). (Photo by Yang Denghong/Xinhua)
